BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 87297)

  • 1. [Serologic breast cancer follow-up monitoring using pregnancy-associated alpha-2-glycoproteins].
    Bauer HW; Hasselblatt I; Husfeldt KJ; Bohn H
    Chir Forum Exp Klin Forsch; 1977 Apr; ():69-72. PubMed ID: 87297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
    Shimizu Y; Oshima K; Nakano Y; Fujita M; Taguchi T
    Biken J; 1981 Sep; 24(3):95-102. PubMed ID: 6175310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of alpha-2 pregnancy associated glycoprotein with the clinical course of bronchial carcinoma (author's transl)].
    Bauer HW; Gropp C; Sieber A; Bohn H
    Thoraxchir Vask Chir; 1977 Jun; 25(3):139-45. PubMed ID: 70850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein markers in disease (2). Pregnancy-associated alpha2-glycoprotein and cancer.
    Stimson WH
    J R Coll Surg Edinb; 1978 Jul; 23(4):253-9. PubMed ID: 79652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Macroglobulin family proteins in breast cancer].
    Promzeleva NV; Zorina VN; Zorin NA
    Vopr Onkol; 2012; 58(5):688-90. PubMed ID: 23600290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum concentration of the pregnancy-associated alpha2 glycoprotein (alpha2-PAG, protein of the "pregnancy zone", PZ) in malignant gynecologic diseases].
    Hofmann R; Straube W; Klausch B
    Zentralbl Gynakol; 1979; 101(7):457-63. PubMed ID: 88855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical study of alpha-macroglobulins in breast cancer].
    Dorosevich AE; Kozlov DV
    Arkh Patol; 2005; 67(4):21-5. PubMed ID: 16209293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of TNF alpha, interferon alpha, interleukin 2 and reactivity in the leucocyte migration inhibition test in breast cancer patients.
    Mallmann P; Diedrich K; Mallmann R; Koenig UD; Krebs D
    Anticancer Res; 1991; 11(4):1509-15. PubMed ID: 1746907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical warning of recrudescent mammary cancers by pregnancy-associated alpha-macroglobulin.
    Anderson JM; Stimson WH; Kelly F
    Br J Surg; 1976 Oct; 63(10):819-22. PubMed ID: 62599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of a new tumor marker (M.C.A.) in the breast cancer follow-up.
    Cappellari A; Bagarella M; Corradi G
    Boll Ist Sieroter Milan; 1990; 69(1):315-8. PubMed ID: 2102115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum big endothelin-1 levels in female patients with breast cancer.
    Yildirim Y; Gunel N; Coskun U; Sancak B; Bukan N; Aslan S; Cetin A
    Int Immunopharmacol; 2008 Aug; 8(8):1119-23. PubMed ID: 18550016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ; Adachi I
    Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum level of pregnancy associated glycoprotein (alpha2AP-glycoprotein) in patient with breast cancer (author's transl)].
    Egami T; Uemura K; Uchida M; Yokoyama I; Yamamoto K
    Nihon Gan Chiryo Gakkai Shi; 1978 Jun; 13(3):266-72. PubMed ID: 80438
    [No Abstract]   [Full Text] [Related]  

  • 14. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of CA 15-3 serum levels in breast cancer patients.
    Skrzydlewski Z; Niklinski J; Kiluk S; Kiluk M; Musiatowicz B; Zaremba E; Skrzydlewska E; Klepacki A
    Minerva Chir; 1997 Mar; 52(3):251-4. PubMed ID: 9099053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
    Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophoretic pattern of serum glycoproteins on polyacrylamide disc gel in patients with breast cancer.
    Patel PS; Raval GN; Patel MM; Balar DB; Patel DD
    Anticancer Res; 1996; 16(4A):2089-94. PubMed ID: 8712748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of serum prolactin determination in metastatic breast cancer patients.
    Mujagić Z; Mujagić H
    Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of the pregnancy associated alpha-2-glycoprotein (PAG) in pregnant women with reference to the number of previous pregnancies].
    Gubatz W; Gurr S; Bundschuh G
    Zentralbl Gynakol; 1977; 99(12):718-24. PubMed ID: 70906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pregnancy associated alpha2-glycoprotein (alpha2-PAG) in the serum of patients with gynecologic carcinomas].
    Bauer HW; Kraus H
    Onkologie; 1978 Oct; 1(5):180-3. PubMed ID: 83557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.